Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 243 institutions that hold shares in the stock, with a total of 80.1 Million shares, which have been reported (via 13F filing form) to have a value of $3.1 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Allworth Financial LP
|
Oct 23, 2024 Q3 2024 |
24
shares
|
$927
0.0% of portfolio
|
Q3 2024
Reduced 20.0%
|
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
Nov 25, 2024 Q3 2024 |
20
shares
|
$773
0.0% of portfolio
|
Q3 2024
New holding
|
|
Park Place Capital Corp
Birmingham, AL |
Jan 17, 2025 Q4 2024 |
18
shares
|
$695
0.0% of portfolio
|
Q1 2024
New holding
|
|
Cibc Private Wealth Group, LLC
|
Nov 13, 2024 Q3 2024 |
15
shares
|
$579
0.0% of portfolio
|
Q3 2024
Reduced 98.39%
|
|
Massmutual Trust CO Fsb
|
Jan 16, 2025 Q4 2024 |
15
shares
|
$579
0.0% of portfolio
|
Q4 2024
New holding
|
|
Quest Partners LLC
New York, NY |
Nov 07, 2024 Q3 2024 |
13
shares
|
$502
0.0% of portfolio
|
Q3 2024
Reduced 98.61%
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
8
shares
|
$309
0.0% of portfolio
|
Q3 2024
New holding
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Jan 22, 2025 Q4 2024 |
7
shares
|
$270
0.0% of portfolio
|
Q4 2024
New holding
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
4
shares
|
$154
0.0% of portfolio
|
Q1 2024
Reduced 33.33%
|
|
Cornerstone Planning Group LLC
Fairfield, NJ |
Nov 05, 2024 Q3 2024 |
4
shares
|
$154
0.0% of portfolio
|
Q3 2023
New holding
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Nov 15, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|